A Physicians' Wish List for the Clinical Application of Intestinal Metagenomics

1. Human Microbiome Project Consortium (2012) A framework for human microbiome research. Nature 486: 215–221.

2. TurnbaughPJ, LeyRE, HamadyM, Fraser-LiggettCM, KnightR, et al. (2007) The human microbiome project. Nature 449: 804–810.

3. SellittoM, BaiG, SerenaG, FrickeWF, SturgeonC, et al. (2012) Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS ONE 7: e33387.

4. SjobergV, SandstromO, HedbergM, HammarstromS, HernellO, et al. (2013) Intestinal T-cell responses in celiac disease—impact of celiac disease associated bacteria. PLoS ONE 8: e53414.

5. Henao-MejiaJ, ElinavE, JinC, HaoL, MehalWZ, et al. (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482: 179–185.

6. SobhaniI, TapJ, Roudot-ThoravalF, RoperchJP, LetulleS, et al. (2011) Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE 6: e16393.

7. LinXB, DielemanLA, KetabiA, BibovaI, SawyerMB, et al. (2012) Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats. PLoS ONE 7: e39764.

8. LomanNJ, ConstantinidouC, ChristnerM, RohdeH, ChanJZ, et al. (2013) A culture-independent sequence-based metagenomics approach to the investigation of an outbreak of Shiga-toxigenic Escherichia coli O104:H4. JAMA 309: 1502–1510.

9. WolfeAJ, TohE, ShibataN, RongR, KentonK, et al. (2012) Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol 50: 1376–1383.

10. EckburgPB, BikEM, BernsteinCN, PurdomE, DethlefsenL, et al. (2005) Diversity of the human intestinal microbial flora. Science 308: 1635–1638.

11. RutgeertsP, GoboesK, PeetersM, HieleM, PenninckxF, et al. (1991) Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 338: 771–774.

12. KhanKJ, DubinskyMC, FordAC, UllmanTA, TalleyNJ, et al. (2011) Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 106: 630–642.

13. KruisW, FricP, PokrotnieksJ, LukasM, FixaB, et al. (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53: 1617–1623.

14. LepageP, HaslerR, SpehlmannME, RehmanA, ZvirblieneA, et al. (2011) Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 141: 227–236.

15. ManichanhC, BorruelN, CasellasF, GuarnerF (2012) The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 9: 599–608.

16. SokolH, PigneurB, WatterlotL, LakhdariO, Bermudez-HumaranLG, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105: 16731–16736.

17. GillN, FerreiraRB, AntunesLC, WillingBP, SekirovI, et al. (2012) Neutrophil elastase alters the murine gut microbiota resulting in enhanced Salmonella colonization. PLoS ONE 7: e49646.

18. LuppC, RobertsonML, WickhamME, SekirovI, ChampionOL, et al. (2007) Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2: 119–129.

19. GorkiewiczG, ThallingerGG, TrajanoskiS, LacknerS, StockerG, et al. (2013) Alterations in the colonic microbiota in response to osmotic diarrhea. PLoS ONE 8: e55817.

20. DethlefsenL, RelmanDA (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 108 (Suppl 1) 4554–4561.

21. MorganXC, TickleTL, SokolH, GeversD, DevaneyKL, et al. (2012) Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13: R79.

22. CarlssonAH, YakymenkoO, OlivierI, HakanssonF, PostmaE, et al. (2013) Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis. Scand J Gastroenterol 48: 1136–1144.

23. de VriezeJ (2013) Medical research. The promise of poop. Science 341: 954–957.

24. KumpPK, GrochenigHP, LacknerS, TrajanoskiS, ReichtG, et al. (2013) Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis 19: 2155–2165.

25. LomanNJ, ConstantinidouC, ChanJZ, HalachevM, SergeantM, et al. (2012) High-throughput bacterial genome sequencing: an embarrassment of choice, a world of opportunity. Nat Rev Microbiol 10: 599–606.

26. SoergelDA, DeyN, KnightR, BrennerSE (2012) Selection of primers for optimal taxonomic classification of environmental 16S rRNA gene sequences. ISME J 6: 1440–1444.

27. MueggeBD, KuczynskiJ, KnightsD, ClementeJC, GonzalezA, et al. (2011) Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 332: 970–974.

28. RidauraVK, FaithJJ, ReyFE, ChengJ, DuncanAE, et al. (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341: 1241214.

29. TurnbaughPJ, QuinceC, FaithJJ, McHardyAC, YatsunenkoT, et al. (2010) Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc Natl Acad Sci U S A 107: 7503–7508.

30. YangI, NellS, SuerbaumS (2013) Survival in hostile territory: the microbiota of the stomach. FEMS Microbiol Rev 37: 736–761.

31. FrickeWF, RaskoDA (2014) Bacterial genome sequencing in the clinic: bioinformatic challenges and solutions. Nat Rev Genet 15: 49–55.

32. KuczynskiJ, LauberCL, WaltersWA, ParfreyLW, ClementeJC, et al. (2011) Experimental and analytical tools for studying the human microbiome. Nat Rev Genet 13: 47–58.

33. LeyRE, TurnbaughPJ, KleinS, GordonJI (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022–1023.

34. AtarashiK, TanoueT, OshimaK, SudaW, NaganoY, et al. (2013) Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500: 232–236.

35. KosticAD, ChunE, RobertsonL, GlickmanJN, GalliniCA, et al. (2013) Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14: 207–215.

36. LozuponeCA, StombaughJI, GordonJI, JanssonJK, KnightR (2012) Diversity, stability and resilience of the human gut microbiota. Nature 489: 220–230.